128 related articles for article (PubMed ID: 15372880)
1. [A new method for determination of antithrombin III and its diagnostic significance].
Barkagan ZS; Momot AP; Mamaev AN; Makarov VA; Voiushina TL; Nevedrova OA; Shilova AN; Ziablitskaia NK
Klin Lab Diagn; 2004 Jul; (7):18-21. PubMed ID: 15372880
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin III assay using thrombin in disseminated intravascular coagulation (DIC), other thromboembolic disorders and hepatic diseases.
Saxena V; Mishra DK; Subramanya H; Satyanarayana S; Sharma A
Indian J Pathol Microbiol; 2004 Apr; 47(2):210-2. PubMed ID: 16295470
[TBL] [Abstract][Full Text] [Related]
3. [Clinical importance of the determination of antithrombin III by the use of a chromogenic substrate, in cases of disseminated intravascular coagulation and of acute hepatic insufficiency].
Carmignoto F; Schivo P; Plebani M; Pengo V; Piccini P; Ceriotti G
Quad Sclavo Diagn; 1981 Jun; 17(2):172-81. PubMed ID: 7267980
[TBL] [Abstract][Full Text] [Related]
4. [Antithrombin III dosage using the chromogenic substrate Tos-Gly-Pro-Arg-NAN, in several pathological situations].
Lourenço DM; Noguti MA; Juliano L
Rev Assoc Med Bras (1992); 1995; 41(6):373-8. PubMed ID: 8733245
[TBL] [Abstract][Full Text] [Related]
5. [Advances in the laboratory diagnosis of disorders of hemostasis].
Sawicka B
Pol Tyg Lek; 1985 Jul; 40(28):806-9. PubMed ID: 3903694
[No Abstract] [Full Text] [Related]
6. [Antithrombin III: its functional characteristics and clinical importance].
Ena IaM; Platonova TN; Sushko EA; Shevchuk TV; Shekhter IE
Lik Sprava; 1993 Sep; (9):18-23. PubMed ID: 8085340
[No Abstract] [Full Text] [Related]
7. [Assay for activity of heparin-antithrombin III complex during treatment of DIC with heparin and its clinical significance].
Tomihara T; Shimazu C; Yasuda K; Kazama M; Abe T
Rinsho Byori; 1986 Feb; 34(2):179-84. PubMed ID: 3702087
[No Abstract] [Full Text] [Related]
8. [Relevance of antithrombin III in thrombogenesis: the diagnosis and therapy of antithrombin III defects].
Wenzel E; Hellstern P; Dumitrescu-Demma E; Miyashita C; Köhler M
Z Gesamte Inn Med; 1984 May; 39(10):220-7. PubMed ID: 6464516
[TBL] [Abstract][Full Text] [Related]
9. [Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency].
Gerhards H
Tierarztl Prax; 1987; 15(1):47-55. PubMed ID: 3590168
[TBL] [Abstract][Full Text] [Related]
10. Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.
Sawamura A; Gando S; Hayakawa M; Hoshino H; Kubota N; Sugano M
Clin Appl Thromb Hemost; 2009 Oct; 15(5):561-6. PubMed ID: 18840625
[TBL] [Abstract][Full Text] [Related]
11. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
[TBL] [Abstract][Full Text] [Related]
12. Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated method.
Frantzen Handeland G; Abildgaard U; Aasen AO
Scand J Haematol; 1983 Nov; 31(5):427-36. PubMed ID: 6648356
[TBL] [Abstract][Full Text] [Related]
13. Fluorometric assay of antithrombin III. Diagnostic value in 112 patients with abnormal hemostasis.
Napoli VM; Krzyzaniak R; Vroon DH; Newton JL
Am J Clin Pathol; 1985 Aug; 84(2):173-9. PubMed ID: 4025221
[TBL] [Abstract][Full Text] [Related]
14. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
Bokarev IN; Butorov VN; Loginov LE
Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
[No Abstract] [Full Text] [Related]
15. [Comparison between anticoagulant activity and antigenicity of plasma antithrombin III in healthy subjects and patients with disseminated intravascular coagulation (DIC) (author's transl)].
Matsuda T; Ogawara M; Miura R; Seki T; Yokouchi M; Murakami M; Fujisawa M; Nakanishi K; Nakamura S
Rinsho Ketsueki; 1980 Mar; 21(3):341-6. PubMed ID: 6157843
[No Abstract] [Full Text] [Related]
16. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I
Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
[No Abstract] [Full Text] [Related]
17. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
Cancer; 1983 Feb; 51(4):681-5. PubMed ID: 6571800
[TBL] [Abstract][Full Text] [Related]
18. Low antithrombin III in acute hepatic failure at term.
Mosvold J; Abildgaard U; Jenssen H; Andersen R
Scand J Haematol; 1982 Jul; 29(1):48-50. PubMed ID: 6812211
[No Abstract] [Full Text] [Related]
19. [Plasma level of activated factor IX-antithrombin III complex in hypercoagulable state].
Sugiura I; Takahashi I; Kagami K; Takamatsu J
Rinsho Byori; 1990 Jul; Suppl 86():149-57. PubMed ID: 2232236
[No Abstract] [Full Text] [Related]
20. [Measurement of thrombin-antithrombin III complex in plasma].
Kuroso K; Koike K; Ikematsu S; Fujimaki M
Rinsho Byori; 1988 Dec; 36(12):1421-5. PubMed ID: 3074186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
